Cargando…
Thrombomodulin activation driven by LXR agonist attenuates renal injury in diabetic nephropathy
OBJECTIVE: Inflammation and thrombosis are recognized as interrelated biological processes. Both thrombomodulin (TM) and factor XIII-A (FXIII-A) are involved in inflammation and coagulation process. However, their role in the pathogenesis of diabetic nephropathy (DN) remains unclear. In vitro study,...
Autores principales: | Wang, Wei, Wu, Song, Wang, Amanda Y., Wu, Tao, Luo, Haojun, Zhao, Jia Wei, Chen, Jin, Li, Yi, Ding, Hanlu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870310/ https://www.ncbi.nlm.nih.gov/pubmed/36698821 http://dx.doi.org/10.3389/fmed.2022.916620 |
Ejemplares similares
-
Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases
por: Griffett, Kristine, et al.
Publicado: (2023) -
Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
por: Wu, Guangzhen, et al.
Publicado: (2019) -
Identfication of Potent LXRβ-Selective Agonists without LXRα Activation by In Silico Approaches
por: Chen, Meimei, et al.
Publicado: (2018) -
Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia
por: Kratzer, Adelheid, et al.
Publicado: (2009) -
Idiopathic membranous nephropathy with renal amyloidosis: A case report
por: Wang, Yue, et al.
Publicado: (2022)